Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether AG-1749 (lansoprazole), once daily (QD), is
effective in preventing the recurrence of gastric and duodenal ulcers in patients receiving
long term treatment with nonsteroid anti-inflammatory drug, compared to gefarnate, twice
daily (BID).